We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our
cookie policy
.
OK
Company-detail.com
Home
Terms
Contact
list of NY corporations
F.D.A. Authorizes AstraZeneca Drug for People With Immune Problems
The antibody drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.
read more
Source: NY Times
00:03, December 9, 2021
Rebecca Robbins
You may also like
Biden Orders Federal Vehicles and Buildings to Use Renewable Energy by 2050
00:06, December 9, 2021
Lisa Friedman
Lawmakers Urge Instagram's Adam Mosseri to Better Protect Children
00:13, December 9, 2021
Cecilia Kang
Apple can delay changes to App Store rules, appeals court says.
00:13, December 9, 2021
The New York Times
U.S. Threat to Squeeze Russia’s Economy Is a Tactic With a Mixed Record
00:30, December 9, 2021
Patricia Cohen
Pfizer Says Its Booster Is Effective Against Omicron
02:14, December 9, 2021
Sharon LaFraniere
Senate Votes to Scrap Biden Vaccine Mandate as Republicans Eye 2022
02:25, December 9, 2021
Emily Cochrane
The Era of the Celebrity Meal
23:26, December 8, 2021
Anna P. Kambhampaty and Julie Creswell
Cryptocurrency Chiefs Go to Congress for Landmark Hearing
23:01, December 8, 2021
Ephrat Livni
Elizabeth Holmes' Defense Rests Their Case in Fraud Trial
22:10, December 8, 2021
Erin Griffith
Manatees, Facing a Crisis, Will Get a Bit of Help: Extra Feeding
21:19, December 8, 2021
Catrin Einhorn
Apple Can Delay Changes to App Store Rules, Appeals Court Says.
21:13, December 8, 2021
Kellen Browning
Number of People Quitting Jobs Remained Near Record High in October
20:59, December 8, 2021
Nelson D. Schwartz
News
Sony in Talks to Join a Bid to Buy Paramount
00:37, April 19, 2024
Benjamin Mullin and Lauren Hirsch
Chinese Exports Are Threatening Biden’s Industrial Agenda
00:26, April 19, 2024
Jim Tankersley and Alan Rappeport
Netflix Added More Than 9 Million Subscribers in First Quarter
00:03, April 19, 2024
Nicole Sperling and Benjamin Mullin